43 related articles for article (PubMed ID: 22846199)
1. Role of
Altini C; Asabella AN; Tramacere F; Sardaro A; Pisani AR; Castelluccia A; Rubini D; Ferrari C
Mol Imaging Radionucl Ther; 2024 Feb; 33(1):1-10. PubMed ID: 38390705
[TBL] [Abstract][Full Text] [Related]
2. Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer.
Sepulcri M; Fusella M; Cuppari L; Zorz A; Paiusco M; Evangelista L
Clin Transl Radiat Oncol; 2021 Sep; 30():71-77. PubMed ID: 34409175
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
Bolcaen J; Descamps B; Deblaere K; De Vos F; Boterberg T; Hallaert G; Van den Broecke C; Vanhove C; Goethals I
PLoS One; 2021; 16(3):e0248193. PubMed ID: 33667282
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI and
Chung YH; Yu CF; Chiu SC; Chiu H; Hsu ST; Wu CR; Yang CL; Hong JH; Yen TC; Chen FH
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1733-1744. PubMed ID: 31127350
[TBL] [Abstract][Full Text] [Related]
5. Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach.
Rattner J; Bathe OF
Metabolites; 2017 Nov; 7(4):. PubMed ID: 29144383
[TBL] [Abstract][Full Text] [Related]
6. Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer.
Amin S; Bathe OF
BMC Cancer; 2016 Nov; 16(1):850. PubMed ID: 27814715
[TBL] [Abstract][Full Text] [Related]
7. Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.
Challapalli A; Aboagye EO
Front Oncol; 2016; 6():44. PubMed ID: 26973812
[TBL] [Abstract][Full Text] [Related]
8. Early assessment of radiation response using a novel functional imaging modality -- [18F]fluorocholine PET (FCH-PET): a pilot study.
Parashar B; Wernicke AG; Rice S; Osborne J; Singh P; Nori D; Vallabhajosula S; Goldsmith S; Chao KS
Discov Med; 2012 Jul; 14(74):13-20. PubMed ID: 22846199
[TBL] [Abstract][Full Text] [Related]
9. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
[TBL] [Abstract][Full Text] [Related]
10. Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
Wallace MC; Sek K; Francis RJ; Samuelson S; Ferguson J; Tibballs J; Asad A; Preen DB; MacQuillan G; Garas G; Adams LA; Jeffrey GP
Dig Dis Sci; 2020 Feb; 65(2):647-657. PubMed ID: 31440998
[TBL] [Abstract][Full Text] [Related]
11. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
Balogova S; Huchet V; Kerrou K; Nataf V; Gutman F; Antoine M; Ruppert AM; Prignon A; Lavolée A; Montravers F; Mayaud C; Cadranel J; Talbot JN
Nucl Med Commun; 2010 May; 31(5):389-97. PubMed ID: 20145579
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]